Unknown

Dataset Information

0

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma.


ABSTRACT: Aim:Metastatic melanoma patients were treated with patient-specific vaccines consisting of autologous dendritic cells loaded with antigens from irradiated cells from short-term autologous tumor cell lines. Patients & methods:A total of 72 patients were enrolled in a single-arm Phase I/II (NCT00948480) trial or a randomized Phase II (NCT00436930). Results:Toxicity was minimal. Median overall survival (OS) was 49.4 months; 5-year OS 46%. A 5-year OS was 72% for 18 recurrent stage 3 without measurable disease when treated and 53% for 30 stage 4 without measurable disease when treated. A total of 24 patients with measurable stage 4 when treated (median of four prior therapies) had an 18.5 months median OS and 46% 2-year OS. Conclusion:This dendritic cell vaccine was associated with encouraging survival in all three clinical subsets. Clinicaltrial.gov NCT00436930 and NCT00948480.

SUBMITTER: Dillman RO 

PROVIDER: S-EPMC6688559 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma.

Dillman Robert O RO   Cornforth Andrew N AN   McClay Edward F EF   Depriest Carol C  

Melanoma management 20190531 2


<h4>Aim</h4>Metastatic melanoma patients were treated with patient-specific vaccines consisting of autologous dendritic cells loaded with antigens from irradiated cells from short-term autologous tumor cell lines.<h4>Patients & methods</h4>A total of 72 patients were enrolled in a single-arm Phase I/II (NCT00948480) trial or a randomized Phase II (NCT00436930).<h4>Results</h4>Toxicity was minimal. Median overall survival (OS) was 49.4 months; 5-year OS 46%. A 5-year OS was 72% for 18 recurrent s  ...[more]

Similar Datasets

| S-EPMC5840808 | biostudies-literature
| S-EPMC4970903 | biostudies-literature
| S-EPMC3651040 | biostudies-literature
| S-EPMC8609477 | biostudies-literature
| S-EPMC6731107 | biostudies-literature
| S-EPMC4556596 | biostudies-literature
| S-EPMC7592424 | biostudies-literature
| S-EPMC3525747 | biostudies-literature
| S-EPMC8593702 | biostudies-literature
| S-EPMC7650380 | biostudies-literature